153 related articles for article (PubMed ID: 12201581)
1. Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis.
Färnert A; Tengstam K; Palme IB; Bronner U; Lebbad M; Swedberg G; Björkman A
Am J Trop Med Hyg; 2002 May; 66(5):487-91. PubMed ID: 12201581
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum: pfcrt and DHFR mutations are associated with failure of chloroquine plus proguanil prophylaxis in travelers.
Durand R; Jafari S; Bouchaud O; Ralaimazava P; Keundjian A; Le Bras J
J Infect Dis; 2001 Dec; 184(12):1633-4. PubMed ID: 11740746
[No Abstract] [Full Text] [Related]
4. Proguanil resistance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing.
Parzy D; Doerig C; Pradines B; Rico A; Fusai T; Doury JC
Am J Trop Med Hyg; 1997 Dec; 57(6):646-50. PubMed ID: 9430520
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
7. Atovaquone/Proguanil Resistance in an Imported Malaria Case in Chile.
Chenet SM; Oyarce A; Fernandez J; Tapia-Limonchi R; Weitzel T; Tejedo JR; Udhayakumar V; Jercic MI; Lucchi NW
Am J Trop Med Hyg; 2021 Mar; 104(5):1811-1813. PubMed ID: 33782210
[TBL] [Abstract][Full Text] [Related]
8. Mutations in dhfr in Plasmodium falciparum infections selected by chlorproguanil-dapsone treatment.
Curtis J; Maxwell CA; Msuya FH; Mkongewa S; Alloueche A; Warhurst DC
J Infect Dis; 2002 Dec; 186(12):1861-4. PubMed ID: 12447777
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria.
Happi CT; Gbotosho GO; Sowunmi A; Falade CO; Akinboye DO; Gerena L; Kyle DE; Milhous W; Wirth DF; Oduola AM
Am J Trop Med Hyg; 2004 Jan; 70(1):20-6. PubMed ID: 14971693
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
11. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
[TBL] [Abstract][Full Text] [Related]
12. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
McKeage K; Scott L
Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
[TBL] [Abstract][Full Text] [Related]
13. DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France.
Durand R; Ramiliarisoa O; Sécardin Y; Eldin de Pécoulas P; Basco LK; Le Bras J
Trans R Soc Trop Med Hyg; 1997; 91(4):460-1. PubMed ID: 9373655
[No Abstract] [Full Text] [Related]
14. Plasmodium falciparum multiple infections, disease severity and host characteristics in malaria affected travellers returning from Africa.
Nicastri E; Paglia MG; Severini C; Ghirga P; Bevilacqua N; Narciso P
Travel Med Infect Dis; 2008 Jul; 6(4):205-9. PubMed ID: 18571110
[TBL] [Abstract][Full Text] [Related]
15. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.
Kublin JG; Dzinjalamala FK; Kamwendo DD; Malkin EM; Cortese JF; Martino LM; Mukadam RA; Rogerson SJ; Lescano AG; Molyneux ME; Winstanley PA; Chimpeni P; Taylor TE; Plowe CV
J Infect Dis; 2002 Feb; 185(3):380-8. PubMed ID: 11807721
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
[TBL] [Abstract][Full Text] [Related]
18. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
Biswas S
J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
[TBL] [Abstract][Full Text] [Related]
19. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
20. High chloroquine treatment failure rates and predominance of mutant genotypes associated with chloroquine and antifolate resistance among falciparum malaria patients from the island of Car Nicobar, India.
Das MK; Lumb V; Mittra P; Singh SS; Dash AP; Sharma YD
J Antimicrob Chemother; 2010 Jun; 65(6):1258-61. PubMed ID: 20363804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
